The mark consists of the word "Syngene" in stylized font.
Mark For: SYNGENE® trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of the word "Syngene" in stylized font.
Research | OneLook Acronym Finder |
Serial Number | 88081490 |
Registration Number | 6531176 |
Mark Literal Elements | SYNGENE |
Mark Drawing Type | 5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM |
Mark Type | TRADEMARK. SERVICE MARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | DIVISIONAL UNIT 2021-05-26 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Domestic Representative | Lawrence E. Abelman |
Attorney Name | Lawrence E. Abelman |
Attorney Docket Number | 879374 |
Law Office Assigned | M70 |
Employee Name | BRACEY, KAREN E |
2018-08-16 | Application Filed |
2019-12-12 | Location: PUBLICATION AND ISSUE SECTION |
2019-12-12 | Status: Live/Pending |
2019-12-25 | Transaction Date |
2020-01-14 | Published |
2020-01-14 | Published for Opposition |
2021-03-01 | Status: A first request for extension of time to file a Statement of Use has been granted. |
2021-05-26 | Location: DIVISIONAL UNIT |
2021-10-19 | Trademark Registered |
Party: | SYNGENE INTERNATIONAL LIMITED |
Address | Biocon Special Economic Zone,Biocon Park Plot No.2&3 Bommasandra IV Phase, Jigani Link Rd, Bangalore INDIA Karnataka |
Legal Entity Type | Corporation |
Legal Entity State | INDIA |
IC 001. US 001 005 006 010 026 046. G & S: Biotechnological products and preparations for laboratory use, namely, enzymes, protein carbohydrates, lipids, and nucleic acids, DNA products, immunological re-agents, and fine chemicals including organic intermediates; active chemical ingredients for use in the manufacture of pharmaceuticals for treating diseases and conditions, involving areas namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, diabetes, multiple sclerosis, acne; assays for research purposes; biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for laboratory, research, clinical or medical laboratory use; unprocessed chemical polymers; chemicals for use in biotechnological product development; chemicals, namely, chitosan; chitosan for industrial purposes; aldehydes; chromatography chemicals; cells for scientific, laboratory or medical research; reagents for use in the development of hybridoma antibodies for other than for medical or veterinary purposes; nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; nucleotides for scientific and research use; protein arrays and nucleotide arrays for scientific and medical research; peptides for industrial purposes; proteins for use in recombinant DNA technology; specialty chemicals, namely, chemical additives for industrial use in the manufacture of a wide variety of oods; chemical reference standards for use in science and industry; isotopes for industrial purposes; biochemicals for in vitro and in vivo scientific use; biochemicals, namely, monoclonal antibodies for use in vitro scientific or research; assays for research purposes; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes
IC 005. US 006 018 044 046 051 052. G & S: Biological and biotechnological chemicals and chemical preparations and formulations thereof for pharmaceutical and medical use; drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; antibodies for use in disease testing; synthetic peptides for pharmaceutical purposes; imaging agents for magnetic resonance imaging ; nucleic acid sequences and chemical reagents for medical and veterinary purposes; pharmaceutical preparations and substances for use in oncology; biological tissue grafts; vascular grafts comprised of living tissue; biopharmaceuticals for the treatment of cancer; yeast and yeast extracts for medical, veterinary or pharmaceutical purposes; proteins and protein arrays for use in recombinant DNA technology for medical and diagnostic purposes; regulatory proteins for medical and diagnostic use; medicines for veterinary purposes; isotopes for medical purposes; biological preparations for medical purposes for treating disease and conditions involving areas, namely, oncology, endocrinology and metabolic diseases, cardio vascular, neuro muscular, dental, dermatological, urological, nephrological, immunological, genetics, ophthalmology, meningitis, asthma; chemical preparations for use in medical DNA analysis for diagnostic and treatment purposes; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; and none of the aforesaid goods relating to chemicals used for agrochemicals purposes, chemicals used for horticulture purposes, chemicals used for forestry purposes and chemicals used for grain production purposes
IC 009. US 021 023 026 036 038. G & S: BIOREACTORS FOR LABORATORY USE
IC 010. US 026 039 044. G & S: SURGICAL, MEDICAL, DENTAL AND VETERINARY INSTRUMENTS AND APPARATUS, namely, ARTIFICIAL LIMBS EYES AND TEETH
IC 016. US 002 005 022 023 029 037 038 050. G & S: Paper and paper articles, namely, writing paper, notebooks, sketch pads, letterhead paper, envelopes, file folders, printed brochures, leaflet, informational flyers and pamphlets in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; printers type and printing clichés, namely, stereotypes; directories in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; printed sign boards, banners, table calendars, and printed certificates; pens and pencils; cardboard and cardboard articles, namely, boxes, packing material, containers, and paper bags; printed matter in the nature of newspapers for general circulation; periodicals in the nature of general features magazines; books in the field of science; bookbinding materials; printed photographs; stationery; adhesive materials for stationery and office use; artists materials, namely, paint, drawing paper, canvas, pens; paint brushes; typewriters and office requisites other than furniture, namely, rubber bands, staplers, paper hole-punches, pen stands, adhesive note paper; printed instructional and teaching materials other than apparatus in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; printers type and printing clichés, namely, stereotypes; directories in the field of science, biology, genetics, chemistry, formulations, antibodies, antibody technology, chemistry, bioinformatics, biomedical devices, biologics, biotechnology, biotherapeutics, biology, biochemical preparations, cell lines, cheminformatics, genetics and genetic engineering, gene expression systems, in vitro research, inhalation pharmaceuticals, molecular sciences, micro-organisms, nutrition, ophthalmic preparations, pharmacogenetics, pharmacokinetics, pharmacology, pharmaceuticals, polymers, peptide synthesis, protein, and solid state characterization; blank journals; printed training materials in the field of clinical study, medical writing and pharmacovigilance services; none of the aforesaid goods relating to gel imaging and gel analysis applications; none of the aforesaid goods used for packaging of agrochemical products and seeds
IC 039. US 100 105. G & S: STORAGE OF HUMAN CELLS
IC 040. US 100 103 106. G & S: Treatment of materials by polymerization; custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, medicines, drugs by pharmaceutical compounders; contract manufacturing in the field of pharmaceuticals and drug development
IC 044. US 100 101. G & S: Medical diagnostic testing, monitoring and reporting services; preparation of reports relating to medical matters; services for the testing of urine; pathology services for medical and diagnostic purposes; behavioral analysis in response to chemicals for medical purposes
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 9 |
U.S. Codes: | 021,023,026,036,038 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
International Codes: | 16 |
U.S. Codes: | 002,005,022,023,029,037,038,050 |
International Codes: | 35 |
U.S. Codes: | 100,101,102 |
International Codes: | 39 |
U.S. Codes: | 100,105 |
International Codes: | 40 |
U.S. Codes: | 100,103,106 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
International Codes: | 44 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
CC0000 | Color is not claimed as a feature of the mark. |
CC0000 | Color is not claimed as a feature of the mark. |
Description | Date | Proceeding Number |
---|---|---|
DIVISIONAL PROCESSING COMPLETE | 2021-05-26 | |
CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2021-05-26 | 67534 |
TEAS REQUEST TO DIVIDE RECEIVED | 2021-05-06 | |
DIVISIONAL REQUEST RECEIVED | 2021-05-06 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2021-03-03 | |
TEAS EXTENSION RECEIVED | 2021-03-01 | |
EXTENSION 1 GRANTED | 2021-03-01 | 98765 |
EXTENSION 1 FILED | 2021-03-01 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2020-09-01 | |
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | 2020-07-23 | |
CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED | 2020-06-26 | 86882 |
ASSIGNED TO PETITION STAFF | 2020-06-24 | 86882 |
TEAS POST PUBLICATION AMENDMENT RECEIVED | 2020-06-02 | 1111 |
EXTENSION OF TIME TO OPPOSE RECEIVED | 2020-02-11 | |
PUBLISHED FOR OPPOSITION | 2020-01-14 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2020-01-14 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-12-25 | |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-12-12 | |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-12-11 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-12-11 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-12-11 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2019-06-11 | 6325 |
NON-FINAL ACTION WRITTEN | 2019-06-11 | 74782 |
NON-FINAL ACTION E-MAILED | 2019-06-11 | 6325 |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2019-06-04 | 88889 |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2019-06-04 | |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-06-04 | |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2019-06-04 | 88889 |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2018-12-06 | 6325 |
NON-FINAL ACTION WRITTEN | 2018-12-06 | 74782 |
NON-FINAL ACTION E-MAILED | 2018-12-06 | 6325 |
ASSIGNED TO EXAMINER | 2018-12-03 | 74782 |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-08-25 | |
NEW APPLICATION ENTERED IN TRAM | 2018-08-20 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.